secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2024-10-28T23:59:59+00:00
Accession:  0000950170-24-117723
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kezar Life Sciences announces 1-for-10 reverse stock split effective Oct 29, 2024
--------------------------------------------------------------------------------

- Reverse split at 1:10 ratio; shares reduce from 72,962,220 to 7,296,222.
- Effective 5:00 p.m. ET Oct 29; trading on split-adjusted basis starts Oct 30.
- Split aims to regain Nasdaq minimum bid price compliance of $1.00 per share.
- No fractional shares; fractional holders receive rounding up to whole share.
- No change to authorized shares, par value, or trading symbol KZR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000095017024117723/0000950170-24-117723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000095017024117723/kzr-20241028.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-117723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer